CytoMed Therapeutics Limited (GDTC)
USD 2.37
(-6.32%)
USD 2.37
(-6.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 384.74 Thousand | 363.91 Thousand | 113.84 Thousand | 59.46 Thousand | - |
| Cost of Revenue | 2824.97 | 8720.00 | 3504.00 | 4628.00 | - |
| Gross Profit | 381.92 Thousand | 355.19 Thousand | 110.33 Thousand | 54.84 Thousand | - |
| Operating Expenses | 3.69 Million | 1.85 Million | 1.72 Million | 1.25 Million | 612.36 Thousand |
| Selling, General and Administrative Expenses | 370.66 Thousand | 596.73 Thousand | 588.7 Thousand | 154.87 Thousand | 40.35 Thousand |
| Research and Development Expenses | 1.2 Million | 1.52 Million | 1.09 Million | 1.03 Million | 439.86 Thousand |
| Other Expenses | - | -262.93 Thousand | 48.85 Thousand | 63.28 Thousand | - |
| Cost and Expenses | 3.69 Million | 1.85 Million | 1.72 Million | 1.25 Million | 612.36 Thousand |
| Operating Income | -2.91 Million | -1.88 Million | -1.93 Million | -1.25 Million | -606.67 Thousand |
| Interest Expense | - | 125.17 Thousand | 117.69 Thousand | 105.51 Thousand | - |
| Income Tax Expense | 494.82 | 1640.00 | -72.25 Thousand | 112.13 Thousand | - |
| Earnings before Tax | -3.13 Million | -3.12 Million | -2.07 Million | -1.94 Million | -632.61 Thousand |
| Net Income | -3.13 Million | -3.22 Million | -2.07 Million | -1.94 Million | -632.61 Thousand |
| Earnings Per Share Basic | -0.29 | -0.41 | -0.30 | -0.33 | -0.11 |
| Earnings Per Share Diluted | -0.29 | -0.41 | -0.30 | -0.33 | -0.11 |
| Weighted Average Shares Outstanding | 10.63 Million | 7.91 Million | 6.93 Million | 5.89 Million | 5.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.63 Million | 7.91 Million | 6.93 Million | 5.89 Million | 5.55 Million |
| Gross Margin | 0.99 | 0.98 | 0.97 | 0.92 | - |
| EBIT Margin | -6.82 | -4.11 | -14.12 | -16.21 | - |
| Profit Margin | -8.14 | -8.87 | -18.22 | -32.66 | - |
| EBITDA | -2.62 Million | -1.49 Million | -1.6 Million | -963.71 Thousand | -474.67 Thousand |
| Earnings Before Tax Margin | -7.57 | -5.19 | -17.02 | -21.12 | - |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | 84.68 Thousand | 384.74 Thousand | 81.74 Thousand | 105.08 Thousand | 106.78 Thousand |
| Cost of Revenue | 123.87 Thousand | 897.96 | 2824.97 | 866.81 | 151.97 Thousand | 2291.07 |
| Gross Profit | -123.87 Thousand | 83.78 Thousand | 381.92 Thousand | 80.88 Thousand | -46.88 Thousand | 104.49 Thousand |
| Operating Expenses | 1.26 Million | 925.49 Thousand | 3.69 Million | 893.39 Thousand | 1.01 Million | 912.32 Thousand |
| Selling, General and Administrative Expenses | 633.08 Thousand | 119.88 Thousand | - | 115.72 Thousand | 514.86 Thousand | 64.9 Thousand |
| Research and Development Expenses | 633.72 Thousand | 294.91 Thousand | - | 284.68 Thousand | 494.39 Thousand | 304.81 Thousand |
| Other Expenses | -2920.00 | -2380.00 | - | - | -2580.00 | - |
| Cost and Expenses | 1.39 Million | 926.39 Thousand | 3.69 Million | 894.25 Thousand | 1.16 Million | 914.61 Thousand |
| Operating Income | -1.39 Million | -687.02 Thousand | -2.91 Million | -663.19 Thousand | -1.16 Million | -762.52 Thousand |
| Interest Expense | 7278.64 | 7796.07 | - | - | 30.49 Thousand | - |
| Income Tax Expense | 569.04 Thousand | 247.79 | 494.82 | 239.20 | 14.67 Thousand | -53.00 |
| Earnings before Tax | -819.9 Thousand | -748.02 Thousand | -3.13 Million | -722.07 Thousand | -1.6 Million | -810.87 Thousand |
| Net Income | -807.96 Thousand | -748.21 Thousand | -3.13 Million | -722.26 Thousand | -1.61 Million | -810.81 Thousand |
| Earnings Per Share Basic | -0.07 | -0.06 | - | -0.06 | -0.14 | -0.08 |
| Earnings Per Share Diluted | -0.07 | -0.06 | - | -0.06 | -0.14 | -0.08 |
| Weighted Average Shares Outstanding | 11.54 Million | 11.54 Million | 10.63 Million | 11.54 Million | 11.52 Million | 9.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.54 Million | 11.54 Million | 10.63 Million | 11.54 Million | 11.52 Million | 9.72 Million |
| Gross Margin | - | 0.99 | 0.99 | 0.99 | -0.45 | 0.98 |
| EBIT Margin | - | -7.33 | - | -7.33 | -9.63 | -6.43 |
| Profit Margin | - | -8.84 | -8.14 | -8.84 | -15.37 | -7.59 |
| EBITDA | -688.74 Thousand | -620.39 Thousand | - | -598.87 Thousand | -1.01 Million | -686.22 Thousand |
| Earnings Before Tax Margin | - | -8.11 | -7.57 | -8.11 | -11.08 | -7.14 |
CPSS
NAM
AX
2063
MORE
SVNLY